Studies with rubella vaccine (RA 27-3) using the subcutaneous and intranasal routes.
D000293:Adolescent; D000906:Antibodies / Q000032:analysis; D002986:Clinical Trials as Topic; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D009666:Nose; D010919:Placebos; D012409:Rubella / Q000276:immunology; D012411:Rubella Vaccine / Q000008:administration & dosage; D012412:Rubella virus / Q000302:isolation & purification; D014611:Vaccination; D014765:Viral Vaccines / Q000008:administration & dosage*
D000906:Antibodies; D010919:Placebos; D012411:Rubella Vaccine; D014765:Viral Vaccines